Pdt Partners, LLC Molecular Templates, Inc. Transaction History

Pdt Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$9.33 - $14.05 $173,463 - $261,217	-18,592 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$8.48 - $12.23 $287,879 - $415,184	-33,948 Reduced 64.61%	18,592 $175,000
Q3 2020 Nov 16, 2020	BUY	$9.99 - $14.41 $128,471 - $185,312	12,860 Added 32.41%	52,540 $574,000
Q2 2020 Aug 14, 2020	BUY	$12.28 - $17.63 $130,855 - $187,865	10,656 Added 36.71%	39,680 $547,000
Q1 2020 May 15, 2020	BUY	$11.31 - $18.26 $205,016 - $330,999	18,127 Added 166.35%	29,024 $386,000
Q4 2019 Feb 14, 2020	BUY	$6.44 - $14.21 $70,176 - $154,846	10,897 New	10,897 $152,000

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $7.33M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.